Real-World Evidence on Rates of MS Relapse and Healthcare Resource Utilisation Following COVID-19 Vaccination

被引:0
|
作者
Kuranz, S. [1 ]
Landsman-Blumberg, P. [1 ]
Wong, S. [2 ]
Tundia, N. [2 ]
机构
[1] TriNetX LLC, Cambridge, MA USA
[2] EMD Serono Res & Dev Inst Inc, Merck KGaA, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-164
引用
收藏
页码:287 / 288
页数:2
相关论文
共 50 条
  • [41] Agreement of COVID-19 incidence between the authoritative data and real-world evidence in England
    Li, Xintong
    Raventos, Berta
    Guo, Yuchen
    Du, Mike
    Burn, Edward
    Prieto-Alhambra, Daniel
    Sabate, Marti Catala
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 442 - 442
  • [42] Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
    Bechman, Katie
    Galloway, James
    LANCET RHEUMATOLOGY, 2023, 5 (03): : e114 - e115
  • [43] Real-World Evidence of COVID-19 Patients' Data Quality in the Electronic Health Records
    Binkheder, Samar
    Asiri, Mohammed Ahmed
    Altowayan, Khaled Waleed
    Alshehri, Turki Mohammed
    Alzarie, Mashhour Faleh
    Aldekhyyel, Raniah N.
    Almaghlouth, Ibrahim A.
    Almulhem, Jwaher A.
    HEALTHCARE, 2021, 9 (12)
  • [44] Real-World Clinical Characteristics of COVID-19 Patients With or Without Evidence of Allergic Asthma
    Kaner, R. J.
    Murphy, T. R.
    Holweg, C.
    Rajput, Y.
    Raimundo, K.
    Seetasith, A.
    Meyer, C. S.
    Iqbal, A.
    Busse, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [45] COVID-19 outcomes and vaccination to SARS-CoV-2 in siponimod treated patients: clinical trial and real-world evidence
    Schreiber, H.
    Hoffmann, O. H.
    Weiss, C.
    Winkelmann, V. E.
    Bopp, T.
    Ziemssen, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 503 - 503
  • [46] Real-World COVID-19 Vaccine Protection Rates against Infection in the Delta and Omicron Eras
    Zhu, Yuru
    Gu, Jia
    Qiu, Yumou
    Chen, Song Xi
    RESEARCH, 2023, 6
  • [47] Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan
    Saita, Mizue
    Yan, Yan
    Ito, Kanami
    Sasano, Hiroshi
    Seyama, Kuniaki
    Naito, Toshio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (01) : 116 - 119
  • [48] Comparison of Incidence and Clinical Outcomes of COVID-19 among Healthcare Workers in the Pre- vaccination and Post-vaccination Periods: A Real-world Impact Study
    Surme, Serkan
    Copur, Betul
    Bayramlar, Osman Faruk
    Tuncer, Gulsah
    Ozdemir, Yusuf Emre
    Pehlivanoglu, Filiz
    Sengoz, Gonul
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2022, 60 (04): : 310 - 317
  • [49] HEALTHCARE RESOURCE UTILISATION AND COSTS ASSOCIATED WITH THE MANAGEMENT OF HOSPITALISED COVID-19 PATIENTS IN ENGLAND
    Patel, V
    Beecroft, S.
    Birch, H. J.
    Gibbons, D.
    Hall, G.
    Heaton, D.
    Marston, X.
    Lipunova, N.
    Oliyide, A.
    Wallace, J.
    VALUE IN HEALTH, 2022, 25 (12) : S147 - S148
  • [50] Work Absence Following COVID-19 Vaccination in a Cohort of Healthcare Personnel
    Breeher, Laura E.
    Wolf, Michael E.
    Geyer, Holly
    Brinker, Todd
    Tommaso, Christopher
    Kohlnhofer, Stacy
    Hainy, Caitlin
    Swift, Melanie
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2022, 64 (01) : 6 - 9